Company Profile

NGL FINE-CHEM LTD.

NSE : NABSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE2866.90-47.85 (-1.64 % )
PREV CLOSE (Rs.) 2914.75
OPEN PRICE (Rs.) 2851.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2357
TODAY'S LOW / HIGH (Rs.)2800.00 2920.00
52 WK LOW / HIGH (Rs.) 715 3789.45
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.06
TTM EPS (Rs.) 106.77
P/E Ratio 26.97
Book Value (Rs.) 282.94
Face Value (Rs.) 5
MCap (Rs. in Mn) 17792.71
Price/Earning (TTM) 24.23
Price/Sales (TTM) 6.16
Price/Book (MRQ) 10.18
PAT Margin (%) 6.97
ROCE (%) 13.65
Incorporation Year : 1981

Management Info :

- Chairman Rahul J Nachane - Managing Director

Registered Office :

Address : 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone : 022 2663 6450

Registrar's Details : Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE
NEWS More
17Sep09-17-2021$NGL Fine-Chem informs about issuance of duplicate share certificate NGL Fine-Chem informs about

In compliance with the provisions of Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that ‘Duplicate Share Certificate’ is issued to the shareholder as per the details attached.

The above information is a part of company’s filings submitted to BSE.

In compliance with the provisions of Regulation 39(3) of SEBI (..
30Aug08-30-2021$NGL Fine-Chem informs about issuance of duplicate share certificate NGL Fine-Chem informs about

In compliance with the provisions of Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that ‘Duplicate Share Certificate’ is issued to the shareholder, Subhash Goyal (Folio No: S00552), further details attached.

The above information is a part of company’s filings submitted to BSE.

In compliance with the provisions of Regulation 39(3) of SEBI (..
27Jul07-27-2021$NGL Fine-Chem informs about newspaper advertisement NGL Fine-Chem informs about
Pursuant to Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that it enclosed a copy of the newspaper advertisement published in The Free Press Journal & Navshakti. 

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 47 of SEBI (Listing Obligations & Di..
11Jun06-11-2021$NGL Fine-Chem informs about investors call NGL Fine-Chem informs about

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that the Company participated in the Investors Conference Call on Thursday, 10th June, 2021 on audited financial results for the quarter and financial year ended March 31, 2021. No unpublished price sensitive information was shared/discussed in the meeting. Audio of the conference call has been uploaded at the Company's website: www.nglfinechem.com/investors/notices.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations & Di..
04Jun06-04-2021$NGL Fine-Chern informs about conference call NGL Fine-Chern informs about

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, NGL Fine-Chern has informed that the Company will hold a Conference Call with Investors, on Thursday, 10th June, 2021 at 11.30 am to discuss the Q4 & Audited Financial Results of the Company for the year ended 31st March, 2021 and to discuss business outlook. No price sensitive information will be disclosed or discussed.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (L..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit193.49554.69
Gross Profit 257.46 759.97
Operating Profit 280.49852.31
Net Sales 759.092552.08
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
JB Chem & Pharma (BSE)
 1836.10 (5.26%)
M.Cap ( in Cr)
14172.76
Alkem Laboratories (BSE)
 4001.85 (0.95%)
M.Cap ( in Cr)
47848.12
Kwality Pharma (BSE)
 688.70 (4.99%)
M.Cap ( in Cr)
714.61
Hester Biosciences (BSE)
 2518.75 (0.91%)
M.Cap ( in Cr)
2133.10
Procter&Gamble Healt (BSE)
 5381.55 (0.34%)
M.Cap ( in Cr)
8915.53
Shareholding Pattern More
PROMOTERS 73.81 %
NON-INSTITUTION 26.19 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes